Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Research & Development data on file, last reported at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 19.68% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (down 14.41% YoY), and the FY2025 full-year result was $19.1 million, up 12.19% from the prior year.
• Research & Development fell to $5.1 million in Q1 2026, from $6.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $13.5 million in Q4 2024 to a low of $1.1 million in Q2 2023.
• A 5-year average of $4.3 million and a median of $4.2 million in 2025 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 271.03% in 2024, while the deepest fall reached 72.46% in 2024.
• Tracing CPIX's Research & Development over 5 years: stood at $11.4 million in 2022, then sank by 58.17% to $4.8 million in 2023, then surged by 183.65% to $13.5 million in 2024, then slumped by 54.01% to $6.2 million in 2025, then dropped by 18.42% to $5.1 million in 2026.
• Business Quant data shows CPIX's Research & Development at $5.1 million in Q1 2026, $6.2 million in Q4 2025, and $4.4 million in Q3 2025.